Raiffeisen Bank International’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121 Hold
5
﹤0.01% 783
2026
Q1
$140 Hold
5
﹤0.01% 818
2025
Q4
$105 Sell
5
-2,490
-100% -$62.8K ﹤0.01% 797
2025
Q3
$63.6K Buy
+2,495
New +$61.6K ﹤0.01% 541

Other funds holding PFE

Raiffeisen Bank International's PFE Position: Q2 2026 in Review

Raiffeisen Bank International increased its Pfizer (PFE) stake by 1.4% in Q2 2026, buying an estimated $492K and bringing the position to 1,398,194 shares worth $33.7M. The position accounts for 0.4% of the portfolio, ranked #63.

Raiffeisen Bank International first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $38.7M in Q1 2026. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Raiffeisen Bank International held 1,398,194 shares of Pfizer worth $33.7M as of Q2 2026.
  • Raiffeisen Bank International bought 18,800 Pfizer shares in Q2 2026, an estimated $492K.
  • Pfizer made up 0.4% of Raiffeisen Bank International's portfolio in Q2 2026, its #63 holding.
  • Raiffeisen Bank International first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's Pfizer position peaked at $38.7M in Q1 2026.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.